Fulcrum Therapeutics, Inc.
Price Action
Technical Summary
DOWNTRENDFulcrum Therapeutics, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 4), showing significant lag compared to the market leaders. Earnings growth of 11% provides fundamental context to the price action. Investors should exercise caution due to high volatility (100% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $3.70 | +0.81% | ABOVE |
| 50 SMA | $5.74 | -35.03% | BELOW |
| 100 SMA | $7.09 | -47.39% | BELOW |
| 150 SMA | $8.43 | -55.76% | BELOW |
| 200 SMA | $8.50 | -56.10% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is FULC in an uptrend right now?
FULC has a trend score of 0/4 based on Minervini's Stage Analysis. Currently showing broken structure - 0 of 4 trend criteria are met.
Is FULC overbought or oversold?
FULC's RSI (14) is 37. The stock is in neutral territory, neither overbought nor oversold.
Is FULC outperforming the market?
FULC has a Relative Strength (RS) Rating of 4 out of 99. FULC is currently lagging the broader market.
Where is FULC in its 52-week range?
FULC is trading at $3.73, which is 24% of its 52-week high ($15.74) and 7% above its 52-week low ($2.83).
How volatile is FULC?
FULC has a Beta of 0.89 and 52-week volatility of 100%. It's less volatile than the S&P 500 - generally more stable.